489 related articles for article (PubMed ID: 16753151)
21. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
[TBL] [Abstract][Full Text] [Related]
22. In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.
Stoppelkamp S; Bell HS; Palacios-Filardo J; Shewan DA; Riedel G; Platt B
Exp Neurol; 2011 Jun; 229(2):226-37. PubMed ID: 21295028
[TBL] [Abstract][Full Text] [Related]
23. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
24. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
[TBL] [Abstract][Full Text] [Related]
25. [Phosphorylation of tau and Alzheimer's disease].
García T; Jay D
Gac Med Mex; 2004; 140(3):329-33. PubMed ID: 15259345
[TBL] [Abstract][Full Text] [Related]
26. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.
Ballatore C; Lee VM; Trojanowski JQ
Nat Rev Neurosci; 2007 Sep; 8(9):663-72. PubMed ID: 17684513
[TBL] [Abstract][Full Text] [Related]
27. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
28. Nitration and oligomerization of tau induced by peroxynitrite inhibit its microtubule-binding activity.
Zhang YJ; Xu YF; Chen XQ; Wang XC; Wang JZ
FEBS Lett; 2005 Apr; 579(11):2421-7. PubMed ID: 15848182
[TBL] [Abstract][Full Text] [Related]
29. Tau phosphorylation in neuronal cell function and dysfunction.
Johnson GV; Stoothoff WH
J Cell Sci; 2004 Nov; 117(Pt 24):5721-9. PubMed ID: 15537830
[TBL] [Abstract][Full Text] [Related]
30. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
31. Insights from Drosophila models of Alzheimer's disease.
Cowan CM; Shepherd D; Mudher A
Biochem Soc Trans; 2010 Aug; 38(4):988-92. PubMed ID: 20658990
[TBL] [Abstract][Full Text] [Related]
32. Granular tau oligomers as intermediates of tau filaments.
Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
[TBL] [Abstract][Full Text] [Related]
33. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
Sorrentino G; Bonavita V
Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
[TBL] [Abstract][Full Text] [Related]
34. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.
Hébert SS; Papadopoulou AS; Smith P; Galas MC; Planel E; Silahtaroglu AN; Sergeant N; Buée L; De Strooper B
Hum Mol Genet; 2010 Oct; 19(20):3959-69. PubMed ID: 20660113
[TBL] [Abstract][Full Text] [Related]
35. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein.
Dinoto L; Deture MA; Purich DL
Microsc Res Tech; 2005 Jul; 67(3-4):156-63. PubMed ID: 16104002
[TBL] [Abstract][Full Text] [Related]
36. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
37. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease].
Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA
Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479
[TBL] [Abstract][Full Text] [Related]
38. Single molecule profiling of tau gene expression in Alzheimer's disease.
Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT
J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636
[TBL] [Abstract][Full Text] [Related]
39. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.
Marcus JN; Schachter J
J Neurogenet; 2011 Dec; 25(4):127-33. PubMed ID: 22091726
[TBL] [Abstract][Full Text] [Related]
40. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
